Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This multicenter RCT aims to compare the efficacy and safety of Brivudine versus Famciclovir in treating acute herpes zoster. Primary objective: Evaluate pain reduction via Numeric Pain Rating Scale (NPRS) at Day 30. Secondary objectives: Compare NPRS at Day 3/Day 7/Day 14/Day 90, time to lesion resolution, Postherpetic Neuralgia (PHN) incidence, and safety.
Phase:
PHASE4
Details
Lead Sponsor:
Peking University Third Hospital
Collaborators:
Air Force Military Medical University, China Beijing Hospital of Traditional Chinese Medicine Peking University First Hospital Xuanwu Hospital, Beijing